Swine flu: GlaxoSmithKline will donate 50 million vaccine doses to poor nations

The U.S. may worry about having enough H1N1 vaccine to protect its population from swine flu, but at least it's getting precious doses. Many developing countries, which can't afford the sometimes expensive medication, don't have any at all.

That may change soon. The U.K.'s GlaxoSmithKline (GSK) said Tuesday it will donate 50 million doses of its H1N1 influenza vaccine to developing countries most in need through the World Health Organization. Initial shipments will start by the end of November with shipments to be completed by May 2010, the WHO said. GlaxoSmithKline's move comes as several other pharmaceuticals have pledged similar measures.